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Objectives This study sought to assess the effect of acute alcohol intake on ischemic preconditioning (IPC) in humans using
the clinical model of 2 sequential balloon inflations during a percutaneous coronary intervention (PCI).
Background Ischemic preconditioning is the most potent form of endogenous myocardial protection from irreversible ische-
mic injury. Experimental observations suggest that acute ethanol administration might abolish IPC.
Methods We studied 30 consecutive patients (22 men, mean age 65 years) undergoing elective coronary angioplasty who
were randomized to receive an oral dose of 40 g ethylic alcohol (administered as 149 ml of Gordon’s Gin) or
149 ml of water 30 min before PCI. Intracoronary electrocardiogram was continuously monitored to assess the
greatest ST-segment elevation or depression from baseline.
Results In placebo-treated patients, the change of ST-segment shift during the second inflation was significantly smaller
than that during the first inflation (19.3  9.1 vs. 15.7  8.7, p  0.005). In contrast, in gin-treated patients,
the change of ST-segment shift during the second inflation was significantly greater than that during the first
inflation (18.7  7.2 vs. 22  10, p  0.03). The group–inflation interaction for ST-segment changes was highly
significant (p  0.001).
Conclusions This randomized, prospective study in humans shows that administration of a moderate dose of ethanol abol-
ishes IPC occurring during sequential episodes of myocardial ischemia and is associated with worsening ische-
mia. Based on our study, intake of moderate to high doses of alcoholic beverages should be avoided in patients
at high risk of acute myocardial infarction. (J Am Coll Cardiol 2008;51:271–5) © 2008 by the American
College of Cardiology Foundation


















lschemic preconditioning (IPC) is the most potent form of
ndogenous myocardial protection from irreversible ische-
ic injury. The first demonstration of IPC was obtained in
canine model of myocardial infarction by Murry et al. (1),
ho showed that infarct size was reduced from 29% to 7%
hen prolonged coronary ligation was preceded by short
ycles of ischemia-reperfusion. Ischemic preconditioning
as been shown in several animal species and seems to occur
lso in humans (2).
Moderate alcohol consumption is associated with a lower
isk of cardiovascular events, probably mediated by benefi-
ial effects on inflammation (3), lipids, and coagulation (4).
n contrast, binge and/or heavy drinking with alcohol intake
50 g per session is associated with higher cardiovascular
isk and mortality after acute myocardial infarction (5,6).
rom the Institute of Cardiology, Catholic University of the Sacred Heart, Rome,
taly. This study was funded by the European Research Advisory Board (grant EA
407).w
Manuscript received July 17, 2007; revised manuscript received August 30, 2007,
ccepted September 7, 2007.nterestingly, recent experimental observations indicate that
cute ethanol administration might abolish IPC (7).
Thus, in this study we assessed the effects on IPC of
cute exposure to ethanol in humans using the surrogate
odel set up in previous clinical studies (8), based on the
ssessment of myocardial ischemia during sequential
alloon inflations in the setting of a percutaneous coro-
ary intervention (PCI).
ethods
atients. We studied 30 consecutive patients (22 men;
ean age 65 years, range 51 to 76 years) who underwent
uccessful PCI for an isolated obstructive stenosis (internal
iameter reduction of 70% to 90% at visual analysis) in the
roximal two-thirds of a major epicardial coronary artery.
nclusion and exclusion criteria have been previously de-
cribed (8). All patients gave written informed consent for
articipation in the study, which was approved by our
nstitutional ethics committee.
tudy protocol. In this prospective, randomized, open-
abel, blinded examination study, which was performed
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to 2 groups. One group consisted
of 15 patients who received an
oral dose of 40 g ethanol (admin-
istered as 149 ml of Gordon’s
Gin) 30 min before PCI. The
other group consisted of 15 pa-
tients who received 149 ml water
30 min before PCI. The time of
30 min was chosen to achieve
eak blood levels of ethanol. All patients were on oral
spirin (100 mg), clopidogrel (75 mg), and statins. No
nti-ischemic treatment was given in the last 24 h before
CI. No patient received sublingual or intravenous nitrates in
he last 24 h before the study or throughout the study. Patients
ere not premedicated with diazepam or other sedatives.
The PCI protocol for IPC assessment was previously de-
cribed in detail (8). Briefly, 2 sequential 2-min balloon in-
ations separated by a 5-min interval were performed. The
ntity of ST-segment shift (in millimeters) was measured by
ntracoronary (IC) electrocardiogram (ECG) as an index of
yocardial ischemia during balloon occlusion. Furthermore,
atients were asked to score the intensity of cardiac pain during
schemia by a visual analog scale ranging from 0 to 100.
etermination of blood ethanol levels. In the last 5
in-treated patients, venous blood samples were obtained
or the measurement of ethanol levels using the DRI ethyl
lcohol assay (Microgenics, Freemont, California) at base-
ine and 30 min after gin administration, immediately
efore the study protocol.
tatistical analysis. Comparisons between groups of con-
inuous and categorical variables were performed using an
npaired Student t test and chi-square test, respectively.
ntragroup comparisons were performed using a paired
tudent t test. Two-way analysis of variance for repeated
linical and Angiographiceatures in the 2 G oups of Patients
Table 1 Clinical and AngiographicFeatures in the 2 Groups of Patients
Gin (n  15) Placebo (n  15) p Value
Age (yrs) 62.3 9.3 67.8 8.5 0.1
Gender male, n (%) 11 (73.3) 11 (73.3) 1
Diagnosis, n (%) 1
Stable angina 6 (40) 7 (47)
Unstable angina 9 (60) 8 (53)
Hypertension, n (%) 11 (73.3) 13 (86.7) 0.65
Smoking, n (%) 7 (46.7) 6 (40) 1
Diabetes, n (%) 3 (20) 8 (53.3) 0.12
Family history of IHD, n (%) 7 (46.7) 8 (53.3) 1
Dyslipidemia, n (%) 7 (46.7) 10 (66.7) 0.46
Culprit vessel, n (%) 0.65
LAD 5 (33.3) 5 (33.3)
LCx 5 (33.3) 7 (46.7)
RCA 5 (33.3) 3 (20)
Reference diameter (mm) 2.95 0.51 2.88 0.55 0.73









HD ischemic heart disease; LAD left anterior descending coronary artery; LCx left circumflex
oronary artery; RCA  right coronary artery.easures was used to compare ischemic ECG changes and
ain intensity during balloon inflations in the 2 groups of
atients. Bonferroni correction as a post-hoc test was
pplied for multiple comparisons in case of global statistical
ignificance after a 2-tailed Student t test. Correlations were
erformed using a Pearson test. Data are expressed as
ean  standard deviation if not otherwise specified; p 
.05 was considered significant. Assuming a difference of 6
m in the changes of ST-segment shift from the first to the
econd balloon inflation between the 2 groups, we calculated
hat 15 patients per group were required to have an 80%
ower to detect a statistically significant difference between
roups at p  0.05.
esults
linical, angiographic, and hemodynamic features. Clini-
al and angiographic features were similar in the 2 groups
Table 1). Hemodynamic variables during PCI were also
imilar in the 2 groups and in each group during the first
nd the second balloon inflation (Table 2). The mean time
rom alcohol administration to the first balloon inflation was
1 min (range 28 to 33 min).
yocardial ischemia. The ST-segment before the first
nd the second balloon inflation was at the isoelectric line
oth in placebo and gin-treated patients. Table 3 summa-
izes values of ST-segment shifts and times to 1-mm
T-segment shift on IC-ECG during balloon inflation in
he 2 groups, as well as times to normalization of ST-
egment shift after balloon deflations.
In placebo-treated patients, the change of ST-segment
hift during the second inflation was significantly smaller
han that during the first inflation (19.3  9.1 mm vs.
5.7  8.7 mm, p  0.005). In contrast, in gin-treated
atients, the change of ST-segment shift during the second
nflation was significantly greater than that during the first
emodynamic Features in the 2 Groups of Patients
Table 2 Hemodynamic Features in the 2 Groups of Patients
Gin (n  15) Placebo (n  15) p Value
Systolic arterial pressure
(mm Hg)
Baseline 124 23 132 20 0.31
First inflation 117 33 126 16 0.35
Second inflation 129 16 125 16 0.5
Diastolic arterial pressure
(mm Hg)
Baseline 77 10 78 13 0.7
First inflation 85 8 84 11 0.66
Second inflation 90 12 84 11 0.13
Heart rate (beats/min)
Baseline 72 10 75 14 0.5
First inflation 73 10 78 12 0.22
Second inflation 73 14 74 14 0.82
alues aremeasured at the highest ST-segment shift at intracoronary electrocardiogram during the
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Fig. 1).
ardiac pain. Pain severity during balloon inflation in the
groups of patients is reported in Table 3. In placebo-
reated patients, cardiac pain severity during the second
nflation was less than that during the first inflation (57.8 
3.6 vs. 71.2  27, p  0.0001). In contrast, in gin-treated
atients, cardiac pain severity during the second inflation
as similar to that during the first inflation (61.4  30.5 vs.
8.4  27, p  0.14) (p  0.70 of group-inflation
nteraction for cardiac pain severity) (Fig. 2).
thanol blood levels. Ethanol blood levels, measured in
he last 5 gin-treated patients, were 0 mg/dl at baseline and
anged from 16 to 34 mg/dl immediately before PCI. A
trong correlation was found between the difference of
Figure 1 Plots of Individual Values of ST-Segment Shift on the
During the First and Second Inflation in the 2 Groups
In gin-treated patients (left), ST-segment changes during the second inflation were
placebo-treated patients (right), ST-segment changes during the second inflation w
coronary electrocardiogram.
Values of ST-Segment Shift, Time of Onset of STTime to ST-Segment Shift Normalization, and Ca
Table 3 Values of ST-Segment Shift, Time oTime to ST-Segment Shift Normaliza
ST-segment shift from baseline to ST-segment
maximum on IC-ECG (mm)*
Inflation 1
Inflation 2
Time to 1-mm ST-segment shift (s)§
Inflation 1
Inflation 2






Data are expressed as mean  SD. *Group–inflation interaction is s
‡p  0.01 versus first inflation value. §Group–inflation interaction is s
IC-ECG  intracoronary electrocardiogram.T-segment shift during the first and the second inflation
nd ethanol blood levels before PCI (R  0.90, p  0.037)
Fig. 3).
iscussion
his randomized, prospective study in humans shows that
dministration of a moderate dose of ethanol abolishes IPC
ccurring during repeated episodes of myocardial ischemia
nd is associated with worsening ischemia.
Our findings confirm those of previous studies showing IPC
n humans during sequential balloon inflations in the setting of
CI (9,10). The limitations of the PCI model to assess IPC in
umans have been critically discussed (11,12). However, the
ttenuation of ST-segment elevation during repeated balloon
G
tients
cantly greater than those during the first inflation (p  0.03). Conversely, in
ignificantly less than those during the first inflation (p  0.005). IC-ECG  intra-
ment Shift >1 mm,Pain Severity
et of ST-Segment Shift >1 mm,
and Cardiac Pain Severity
 15) Placebo (n  15) p Value
 7.2 19.3 9.1 0.83
 10† 15.7 8.7‡ 0.07
 7.8 24.4 12.8 0.28
 10.1 31 15.1† 0.04
 5.5 22.9 3.9 0.65
 4.7 23.1 3.5 0.60
 27 71.2 27 0.78
 30.5 57.8 23.6‡ 0.72
ally significant (p  0.0001). †p  0.05 versus first inflation value.
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ardiographic parameters of ischemia, suggesting that ST-
egment shifts are a reliable marker of the severity of ischemia
13,14). Furthermore, previous clinical studies showed that
hanges in coronary hemodynamics are unlikely to explain the
ttenuation of ST-segment shift observed during the second
alloon inflation (9), which is, instead, abolished by treatments
nown to abolish IPC in experimental models (2).
The observation in our study that ethanol abolishes IPC
n humans is in agreement with the experimental data of
renz et al. (7), who found that in rabbits, intravenous
Figure 2 Plots of Individual Values of Cardiac Pain Severity at
In gin-treated patients (left), cardiac pain severity at the end of the second inflatio
in placebo-treated patients (right), cardiac pain severity at the end of the second
Figure 3 Ethanol Blood Levels of the Last 5
Gin-Treated Patients Before Coronary Intervention
In all patients, ethanol blood levels were high at the beginning of the coronary
angioplasty procedure. The correlation between ethanol levels and ST-segment
shift between the first and the second inflation was significant (p  0.037).
  difference of ST-segment shift between second and first inflation;
solid bars  second inflation; open bars  first inflation; Pt  patients.ithanol given 10 min before ischemia prevented IPC. Of
ote, in the same model the effect of ethanol was time-
ependent, because ethanol given 1 h before ischemia
nduced preconditioning-like protection resulting in a re-
uction of infarct size of 26% to 40%. However, in the
abbit, ethanol blood levels (28  2 mg/dl) associated with
his beneficial effect were similar to those associated with
bolition of IPC in our human model. This discrepancy
ay be explained by several factors, including different
oses of alcohol, different dose–effect relationships in
ifferent species, different pharmacokinetics, and differ-
nt end points (12).
Abolition of preconditioning is of clinical relevance.
askey et al. (15) showed that lack of IPC according to IC
r to surface ECG during PCI was associated with poor
rognosis. Ishihara et al. (16) showed that a history of
yocardial infarction, which potentially disrupts protective
ignaling of preconditioning, was associated with lack of
rotection by pre-infarction angina against cardiac events
nd mortality after acute myocardial infarction. Accord-
ngly, abolition of IPC might help explain the higher
ortality after acute myocardial infarction observed in binge
rinkers as compared with those who are not binging
rinkers (6) and the higher cardiovascular risk observed in
eavy and binge drinkers (5).
The reason that in our study acute ethanol exposure was
ssociated with worsening ischemia cannot be deduced by
ur results. Ethanol ingestion has been associated with
atecholamine discharge in humans, which may increase
yocardial oxygen consumption (17). However, we failed to
how significant differences in heart rate and blood pressure
etween gin-treated and placebo-treated patients.
We cannot completely exclude that an effect of ethanol
n the coronary circulation might have contributed to the
egative effect on repeated balloon-induced myocardial
nd of the First and Second Inflation in the 2 Groups of Patients
similar at that at the end of the first inflation (p  0.14). In contrast,
n was significantly less than that at the end of the first inflation (p  0.0001).the E
n was
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January 22, 2008:271–5 Ethanol Abolishes Ischemic Preconditioningailed to show any effect of ethanol on baseline ST-segment
evel and any delay in ST-segment normalization after
alloon deflation.
Another interesting finding in our study is that in
lacebo-treated patients, the severity of angina paralleled
hat of myocardial ischemia, whereas in gin-treated
atients, pain severity during first and second inflation
as similar in spite of worsening ischemia. The reasons
or this dissociation may depend on the analgesic effects
f ethanol (22).
tudy limitations. Some study limitations, in addition to
hose inherent to the PCI model of IPC, must be consid-
red. First, episodes of silent ischemia in the 24 h preceding
he study might have occurred. However, because of the
andomized nature of the study, this event should be
alanced in the 2 groups. Second, we acknowledge that
ome differences existed between the 2 groups. However,
ifferences were not statistically significant and were un-
ikely to account for the different results. Third, the elec-
rophysiological effects of ethanol may have caused
schemic-like ST-segment shifts. However, the baseline
T-segment shift was similar in gin-treated and in placebo-
reated patients. Finally, we did not assess the effects of
ower doses of ethanol on IPC. Our goal, however, was to
rovide a possible mechanistic interpretation of the detri-
ental effects of binge drinking.
onclusions
yocardial preconditioning is a potent form of endoge-
ous protection against ischemic injury. Thus, the dem-
nstration in a human model that acute ethanol admin-
stration abolishes IPC is clinically relevant and suggests
hat intake of moderate to high doses of alcoholic
everages should be avoided in patients at risk for acute
yocardial infarction.
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